Section Review Anti-infectives: The future role of quinolones
- 1 August 1996
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 6 (8) , 711-737
- https://doi.org/10.1517/13543776.6.8.711
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- The rapid emergence of fluoroquinolone-methicillin-resistant Staphylococcus aureus infections in a community hospital: An in vitro look at alternative antimicrobial agentsDiagnostic Microbiology and Infectious Disease, 1992
- Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain ofMycobacterium tuberculosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628Diagnostic Microbiology and Infectious Disease, 1991
- Tuberculosis in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Comparative in vitro activity of fleroxacin (RO 23-6240) againstUreaplasma urealyticum andMycoplasma hominisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Mode of Action, and In Vitro and In Vivo Activities of the FluoroquinolonesThe Journal of Clinical Pharmacology, 1988
- In vitro activity of the two new 4-quinolones A56619 and A56620 againstNeisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum andGardnerella vaginalisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Clinical uses of nalidixic acid analogues: the fluoroquinolonesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- In vitro activity of ciprofloxacin againstBrucella melitensisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984